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Abstract. 
 
Two splice variants of the 
 
a
 
6 integrin sub-
unit, 
 
a
 
6A and 
 
a
 
6B, with different cytoplasmic domains, 
have previously been described. While 
 
a
 
6B is ex-
pressed throughout the development of the mouse, the 
expression of 
 
a
 
6A begins at 8.5 days post coitum and is 
initially restricted to the myocardium. Later in ontog-
eny, 
 
a
 
6A is found in various epithelia and in certain 
cells of the immune system. In this study, we have in-
vestigated the function of 
 
a
 
6A in vivo by generating 
knockout mice deficient for this splice variant. The Cre-
 
loxP
 
 system of the bacteriophage P1 was used to specif-
ically remove the exon encoding the cytoplasmic do-
main of 
 
a
 
6A in embryonic stem cells, and the deletion 
resulted in the expression of 
 
a
 
6B in all tissues that nor-
mally express 
 
a
 
6A
 
.
 
 We show that 
 
a
 
6A
 
2
 
/
 
2
 
 mice de-
velop normally and are fertile. The substitution of 
 
a
 
6A 
by 
 
a
 
6B does not impair the development and function 
of the heart, hemidesmosome formation in the epider-
mis, or keratinocyte migration. Furthermore, T cells 
differentiated normally in 
 
a
 
6A
 
2
 
/
 
2
 
 mice. However, the 
substitution of 
 
a
 
6A by 
 
a
 
6B leads to a decrease in the 
migration of lymphocytes through laminin-coated 
Transwell filters and to a reduction of the number of T 
cells isolated from the peripheral and mesenteric lymph 
nodes. Lymphocyte homing to the lymph nodes, which 
involves various types of integrin–ligand interactions, 
was not affected in the 
 
a
 
6A knockout mice, indicating 
that the reduced number of lymph node cells could not 
be directly attributed to defects in lymphocyte traffick-
ing. Nevertheless, the expression of 
 
a
 
6A might be nec-
essary for optimal lymphocyte migration on laminin in 
certain pathological conditions.
Key words: integrin • laminin receptor • knockout • 
migration • lymphocyte
 
T
 
he
 
 adhesion receptors of the integrin family play a
major role in various physiological and develop-
mental processes by regulating cell adhesion, mi-
gration, differentiation, and proliferation (Hynes, 1992).
Integrins are transmembrane heterodimers formed by
noncovalently linked 
 
a
 
 and 
 
b
 
 subunits. While the extracel-
lular domain of integrins mediates cell–cell or extracel-
lular matrix–cell interactions, the cytoplasmic domain
provides a link with proteins of the cytoskeleton and is in-
volved in the transmission of intracellular signals (Clark
and Brugge, 1995).
16 
 
a
 
 and 8 
 
b
 
 subunits have been identified so far, consti-
tuting a family of over 20 distinct receptors. A further
degree of diversity arises from alternative RNA splicing,
which produces extracellular and cytoplasmic variants of
some of these subunits. Splice variants of the extracellular
domain of 
 
a
 
6 (Delwel et al., 1995), 
 
a
 
7 (Ziober et al., 1993),
and 
 
a
 
II
 
b
 
 (Bray et al., 1990) and of the cytoplasmic domain
of 
 
a
 
3 (Takada et al., 1991), 
 
a
 
6 (Cooper et al., 1991; Hoger-
vorst et al., 1991), 
 
a
 
7 (Song et al., 1993; Ziober et al.,
1993), 
 
b
 
1 (Altruda et al., 1990; Languino and Ruoslahti,
1992; van der Flier et al., 1995; Zhidkova et al., 1995), 
 
b
 
3
(van Kuppevelt et al., 1989; Kumar et al., 1997), and 
 
b
 
4
(Hogervorst et al., 1990; Suzuki and Naitoh, 1990; Tamura
et al., 1990; Clarke et al., 1994; van Leusden et al., 1997)
subunits have been described.
The 
 
a
 
6 subunit dimerizes with either the 
 
b
 
1 or the 
 
b
 
4
subunit to form receptors for various laminin isoforms
(Delwel and Sonnenberg, 1996). Two splice variants of the
cytoplasmic domain of 
 
a
 
6, 
 
a
 
6A and 
 
a
 
6B, have been iden-
tified (Cooper et al., 1991; Hogervorst et al., 1991), the cy-
toplasmic domains of which are encoded by separate ex-
ons and which present entirely different sequences with
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the exception of the GFFKR motif, present in all 
 
a
 
 sub-
units. The 
 
a
 
6A and 
 
a
 
6B mRNA variants are generated by
pre-mRNA splicing in such a way that exon A sequences
are either retained in or removed from the primary tran-
script. In the 
 
a
 
6A transcripts, a stop codon at the 3
 
9
 
 end of
exon A prevents translation to continue further into exon
B. The cytoplasmic sequences of 
 
a
 
6A and 
 
a
 
6B are con-
served in mammalian species, suggesting that the existence
of the two forms may be functionally advantageous. This
hypothesis is further supported by the homologies existing
between the 
 
a
 
6 splice variants and the variants of two
other laminin-binding subunits, 
 
a
 
3 and 
 
a
 
7.
Little is known about the functions of 
 
a
 
6A and 
 
a
 
6B.
Transfection experiments have shown that whether 
 
a
 
6
 
b
 
1
or 
 
a
 
6
 
b
 
4 contain 
 
a
 
6A or 
 
a
 
6B makes no difference in the
regulation of their binding activity or ligand specificity
(Delwel et al., 1993; Shaw et al., 1993
 
a
 
) or the transduction
of inside-out signals, although only the variant A is phos-
phorylated upon phorbolester treatment (Hogervorst et
al., 1993
 
a
 
; Shaw and Mercurio, 1993
 
b
 
). The subcellular lo-
calization of the two variants and their interaction with the
cytoskeleton appear to be cell type specific: while both
variants distribute to the focal contacts in many cell lines,
staining of 
 
a
 
6B revealed a punctate pattern distinct from
focal adhesions in embryonic fibroblasts (Cattelino et al.,
1995). Differential interactions with cytoskeleton proteins
were further suggested by the finding that 
 
a
 
6A induced
the formation of pseudopodia in a macrophage cell line
and promoted cell migration on laminin-1 to a greater
extent than 
 
a
 
6B (Shaw et Mercurio, 1994). This might be
related to the quantitative differences in tyrosine phos-
phorylation of certain proteins, including paxillin, upon li-
gation of integrins containing either of the two variants in
these cells (Shaw et al., 1995). This property of 
 
a
 
6A to fa-
cilitate cell migration was also observed in embryonic stem
(ES)
 
1
 
 cells (Domanico et al., 1997) and could be crucial
during development and tissue remodeling.
The hypothesis that 
 
a
 
6A and 
 
a
 
6B differentially regulate
cell behavior is further supported by their specific distribu-
tion patterns in both embryonic and adult tissues. While
omnipotent mouse ES cells only express the 
 
a
 
6B variant
in vitro, their differentiation was found to be correlated
with the expression of 
 
a
 
6A (Cooper et al., 1991; Hierck et
al., 1993). Similarly, 
 
a
 
6B is found in the earliest stages of
embryonic development, whereas expression of 
 
a
 
6A does
not start until 8.5 days post coitum (dpc) and is initially re-
stricted to the myocardium (Collo et al., 1995; Thorsteins-
dóttir et al., 1995). At this stage, 
 
a
 
6A is present in the
heart in a gradient from strong expression in the atrium to
a weaker expression in the ventricle. By 12.5 dpc, this gra-
dient has disappeared, and 
 
a
 
6A is found in other tissues,
including the epidermis, the gonads, and the epithelium of
the digestive tract (Thorsteinsdóttir et al., 1995). In the
adult mouse, 
 
a
 
6A is expressed in the epidermis, in the epi-
thelia of the mammary gland and the digestive tract, in the
mature gonads, and in Schwann cells (Hogervorst et al.,
1993
 
b
 
; Salanova et al., 1995). However, it is no longer
present in the adult myocardium. From early development
to the adult stage, 
 
a
 
6B is expressed in the kidney, in en-
dothelia, in certain epithelia, and in the nervous system
(Hogervorst et al., 1993
 
b
 
).
Interestingly, the expression of 
 
a
 
6 splice variants is reg-
ulated during the development of thymic endothelial and
stromal cells and cells of the thymocyte/T cell lineage.
Thus, while 
 
a
 
6B is the first variant detected in the thymus
at 10 dpc, 
 
a
 
6A becomes expressed later during ontogeny,
in association with both 
 
b
 
1 and 
 
b
 
4 subunits (Ruiz et al.,
1995). The expression of 
 
a
 
6 on endothelial thymic cells ap-
pears to be important for proper maturation of the im-
mune system since anti-
 
a
 
6 antibodies block homing of T
cell progenitors to the thymus (Ruiz et al., 1995), where
differentiation into CD4
 
1
 
 or CD8
 
1
 
 cells occurs. In the T
cell lineage, 
 
a
 
6A and 
 
a
 
6B are present on immature thy-
mocytes, but mature cells no longer express 
 
a
 
6 (Ruiz et al.,
1995). However, both splice variants are found on human
peripheral blood T lymphocytes (Chang et al., 1995).
Although the spatial and temporal regulation of 
 
a
 
6A
and 
 
a
 
6B expression strongly suggests that the splice vari-
ants have specific functions during embryogenesis as well
as in various organs at the adult age, this has never been
studied in vivo. To answer this question and to test the ten-
tative conclusions from results obtained in vitro, we have
generated exon-specific knockout mice in which the exon
encoding the cytoplasmic domain of 
 
a
 
6A is deleted. As a
consequence, only exon B is inserted in the 
 
a
 
6 mRNA,
which results in the replacement of 
 
a
 
6A by 
 
a
 
6B in all tis-
sues that normally express only 
 
a
 
6A. Classical ES cell
technology allows the generation of null mutations by sim-
ple ablation and replacement of the gene of interest by a
selection marker cassette through homologous recombina-
tion. This approach could not be used in the case of an
exon-specific knockout since the selection marker remain-
ing in the gene after homologous recombination might af-
fect the splicing of the remaining exons. Therefore, we
made use of the Cre-
 
loxP
 
 system of the bacteriophage P1
(Sauer and Henderson, 1988) to subsequently excise the
selection marker cassette in the ES cells after replacement
of exon A.
The analysis of the phenotype of the 
 
a
 
6 exon A–specific
knockout mice confirmed the involvement of 
 
a
 
6A in some
aspects of cell migration but also revealed a number of
surprising and unexpected results.
 
Materials and Methods
Construction of the Targeting Vector
A 14-kb clone containing the exon A encoding the cytoplasmic domain of
a6A and the exon B encoding the cytoplasmic domain of a6B was isolated
from the lFIX-II 129/Sv mouse genomic library (Stratagene, La Jolla,
CA) and used to construct the targeting vector. The exon A and the exon–
intron boundaries were replaced by a BamHI site and a XhoI site using
PCR in the 3-kb XbaI-XbaI DNA fragment (Fig. 1 A). Next, a gene cas-
sette containing the neor gene and the HSV-tk gene flanked by two loxP
sites (a gift of Dr. R. Fässler, Lund University Hospital, Lund, Sweden)
was inserted into the introduced BamHI and XhoI sites. Each selectable
marker gene is under the control of a PGK promoter and contains PGK
poly-adenylation sequences. The final targeting construct contained 2.8 kb
of flanking genomic sequences further upstream from the exon A to the
BglII site, and a 5.5-kb fragment including the exon B downstream from
the exon A to the NsiI site.
1. Abbreviations used in this paper: dpc, days post coitum; ES, embryonic
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Generation of a6A-deficient Mice
E14 ES cells were transfected with 80 mg of the targeting construct by
electroporation. The transfected cells were grown on gelatin and selected
in the presence of G418 (200 mg/ml). Homologous recombinant clones
were identified by Southern blot hybridization with a cDNA probe corre-
sponding to exon B. To excise the neo-tk cassette, several homologous re-
combinant clones were transfected with 10 mg of Cre-encoding plasmid by
electroporation. Transfected cells were grown on irradiated mouse embry-
onic fibroblasts for 48 h. Cells were then trypsinized and seeded on a fi-
broblast monolayer at a density of 3 3 103 ES cells/cm2. Selection with 1.5
mM gancyclovir started 3 d later. Resistant clones were screened by PCR
for the Cre-mediated recombination events using oligonucleotides in the
intronic sequences adjacent to the exon A, 83 bp upstream of the exon A
(59-ACGGCACAGTGACTGCTCGCT-39), and 36 bp downstream of
the exon A (59-GCCACCACAACCACAGCAGGT-39). Two indepen-
dent clones were isolated and expanded, and their karyotype was checked
before injection into C57BL6 blastocysts. Male chimeric mice were bred
with 129/OLA and FVB females to obtain heterozygous a6A1/2 mice,
identified by PCR. Intercrossing of these mice produced offspring ho-
mozygous for the mutation.
Histological Analysis
Whole embryos of 10.5 or 12.5 dpc and tissues from adult mice were col-
lected and fixed in 20% ethanol/5% acetic acid/5% formalin for 48 h, em-
bedded in paraffin, cut into 7-mm sections, and stained with haematoxylin/
eosin.
Immunofluorescence
Whole embryos of 12.5 dpc and skin samples from adult mice were col-
lected and fixed in Tissue-Tek OCT compound (Miles Inc., Elkhart, IN)
and frozen in liquid nitrogen. Cryosections (5 mm) were prepared and air
dried. After blocking with PBS, 2% bovine serum albumin for 1 h, unfixed
sections were incubated with primary antibodies for 1 h at 378C. The fol-
lowing monoclonal antibodies were used: rat anti–integrin a6 (GoH3;
Sonnenberg et al., 1987), mouse anti–a6A (1A10; Hogervorst et al.,
1993a,b) and mouse anti–a6B (PB36; de Melker et al., 1997), mouse anti-
a3A (29A3; de Melker et al., 1997), and rat anti–mouse a7 (CA5; Yao et
al., 1996). After washing in PBS, sections were incubated with FITC-con-
jugated and TRITC-conjugated secondary antibodies (Jackson Immu-
noResearch Laboratories, Inc., West Grove, PA) for 45 min at 378C,
washed again in PBS, and mounted in Vectashield (Vector Laboratories,
Inc., Burlingame CA).
Ultrastructural Analysis
Skin samples from adult mice were collected and fixed in 2.5% glutaralde-
hyde/0.1 M cacodylate buffer, pH 7.2, post-fixed in 1% OsO4/0.1 M ca-
codylate, stained en bloc with UO2Ac2, and embedded in a mixture of
LX112 and Araldite. Thin sections were examined with an electron micro-
scope (model CM10; Philips Electron Optics, Mahwah, NJ).
Wound Healing Experiments
Wounding by tail amputation was conducted as previously described
(Guo et al., 1996). A small section of the tail end was amputated from age-
and sex-matched wild-type and a6A2/2 mice. 2 or 4 d after wounding, an
additional segment of the tail was amputated, fixed in 20% ethanol/5%
acetic acid/5% formalin for 48 h, embedded in paraffin, cut into 7-mm sec-
tions, and stained with haematoxylin/eosin.
Primary Keratinocyte Culture
and Immunoprecipitations
Keratinocytes were isolated and cultured as previously described (Hen-
nings, 1994) with some modifications. In brief, newborn mice were killed
by decapitation, and the tail and limbs were removed. Skin was removed
from the base of the tail to the head and rinsed in PBS containing penicil-
lin/streptomycin, and fat tissue underlying the dermis was discarded. Skins
were floated, dermis side down, on a 0.25% trypsin solution overnight at
48C. Dermis was then removed with forceps and discarded. Epidermis was
minced, and keratinocytes were mechanically isolated by stirring at 48C
for 30 min. The cell suspension was then filtered through a 70-mm nylon
filter, and keratinocytes were centrifuged and seeded on Matrigel (Collab-
orative Biomedical Products, Becton Dickinson Labware, Mountain
View, CA) in SFM keratinocyte medium (GIBCO BRL, Paisley, UK).
From the first passage, cells were grown on tissue culture–treated plastic
dishes.
Immunoprecipitation from lysates of 125I surface-labeled cells was per-
formed as previously described (Hogervorst et al., 1993b) using the fol-
lowing antibodies: anti-a6 (GoH3), anti-a6A (1A10), anti-a6B (PB36),
anti-a3A (29A3), anti–mouse b4 (346-11A; Kennel et al., 1986), and rat
anti–mouse b1 (MB1.2; von Ballestrem et al., 1996).
Keratinocyte Adhesion and Migration
For adhesion assays, subconfluent keratinocytes were trypsinized, washed
twice in SFM medium, seeded in 96-well plates (105 cells/well) previously
coated with laminin-1 (Collaborative Biomedical Products), laminin-5 (a
gift from Dr. P. Rousselle, Institut de Biologie et Chimie des Protéines,
Lyon, France), or fibronectin (Sigma Chemical Co., St. Louis, MO), and
blocked with 1% BSA. After 50 min incubation at 378C, cells were
washed with PBS, fixed with 1% glutaraldehyde, and stained with crystal
violet for 30 min. Cells were then thoroughly washed and solubilized in
0.2% Triton X-100. Adhesion was quantified as a measure for the OD at
540 nm.
For migration assays, 105 keratinocytes were seeded in the upper com-
partment of 8-mm-pore Transwell filters (Costar, Cambridge, MA) previ-
ously coated with 10 mg/ml of laminin-1, laminin-5, or fibronectin on the
lower face of the filter only. After 6 or 18 h of migration, cells in the upper
chamber of the filter were removed, and keratinocytes on the lower side
of the filter were fixed in methanol and stained with crystal violet. The
number of cells under the microscope was assessed by counting a mini-
mum of five fields/filter.
Flow Cytometry
Total cell suspensions from the various lymphoid organs were isolated,
and red blood cells were lysed by routine techniques. Cells were washed
twice in PBS, incubated with purified anti–mouse CD32/CD16 (2.4G2;
PharMingen, San Diego, CA) to block Fcg receptors for 30 min at 48C,
and stained for flow cytometry with the following antibodies from Phar-
Mingen for 30 min at 48C: PE-conjugated anti–mouse CD3e (145-2C11),
FITC-conjugated anti–mouse CD4 (L3T4, RM4-5), PE-conjugated anti–
mouse CD8b.2 (Ly-3.2), FITC-conjugated anti–mouse IgM (R6-60.2), and
biotin-conjugated anti–mouse B220/CD45R. The samples were washed
three times in PBS and analyzed in a FACScan® using CellQuest software
(Becton Dickinson Labware).
T Cell Purification and Proliferation
Axillary, brachial, inguinal, and mesenteric lymph nodes from 2-mo-old
wild-type and a6A2/2 mice were collected, and cells were extracted in Is-
cove’s medium (GIBCO BRL) supplemented with 5% heat inactivated
FCS, penicillin, streptomycin, and 30 mM b-mercaptoethanol. After lysis
of red cells, cell suspensions were first depleted from large adhering cells
by passing them through a nylonwool column (Polysciences, Inc., War-
rington, PA) for 45 min at 378C. Unbound cells (containing T lympho-
cytes) were subjected to further purification on anti-MHCII–coupled
beads (anti–mouse I-Ad/I-Ed antibody 2G9 from PharMingen; beads from
PerSeptive Biosystems, Inc., Framingham, MA). Purity was checked by
FACS® analysis using a PE-conjugated anti–mouse CD3e antibody, and
cell preparations containing less than 97% of CD3-positive cells were dis-
carded.
For proliferation assays, 96-well plates were first coated overnight at
48C with anti-CD3e followed by coating with mouse laminin-1 for 4 h at
378C. T lymphocytes (105 cells/well) were cultured in 5% FCS Iscove’s
medium for 48, 72, or 96 h, pulsed with [3H]thymidine (0.5 mCi/well) for
the last 12 h, and harvested onto glass fiber filter paper. Radioactivity was
determined by liquid scintillation counting. In some cases, anti-CD28 anti-
body (1 mg/ml) was added to the wells.
In Vitro T Cell Migration
5-mm-pore Transwells (Costar) were coated overnight at 48C with lami-
nin-1 or fibronectin at the indicated concentrations on both sides of the fil-
ter and subsequently washed in PBS. SDF-1 or MCP-1 was added to 0.5%
BSA Iscove’s medium (GIBCO BRL) in the lower compartment of the
Transwell only. 105 purified lymph node T lymphocytes (isolated from the
axillary, brachial, inguinal, and mesenteric lymph nodes) were seeded inThe Journal of Cell Biology, Volume 143, 1998 256
the upper compartment of the Transwell in 0.5% BSA Iscove’s medium
and allowed to migrate for 2 h. Migration was terminated by removal of
the filter and counting of the cells collected on the bottom of the well.
In Vivo Homing Assay
Single cell suspensions were prepared from peripheral (axillary, brachial,
and inguinal) and mesenteric lymph nodes from age- and sex-matched
wild-type and a6A2/2 mice and used as lymph node cells. Cells were
washed twice in 0.5% Iscove’s medium (GIBCO BRL) and labeled with
either PKH2 or PKH26 fluorescent cell linkers (Sigma Chemical Co., St.
Louis, MO) according to the manufacturer’s instructions. In brief, cells
were resuspended in diluent C, after which they were immediately added
to an equal volume of a 4 mM PKH2 or PKH26 solution in diluent C. The
final cell concentration was 107 cells/ml. The cells were then incubated at
room temperature for 2 min, after which the staining reaction was stopped
by the addition of an equal volume of FCS. After 1 min, an equal volume
of Iscove’s medium supplemented with 10% FCS was added to the cells.
Cells were then washed four times in the same medium. Labeled a6A1/1
and a6A2/2 cells were mixed in equal number and immediately injected
into the tail vein of wild-type recipient animals (3 3 107 cells for each cell
type). The percentage of PKH2- and PKH26-labeled cells in the cell mix-
ture was checked by FACS® analysis. After 2 or 20 h, mice were killed,
and the spleen, peripheral, and mesenteric lymph nodes were isolated.
Cell suspensions were extracted from each organ, and the percentages of
labeled wild-type (a6A1/1) and a6A2/2 cells were determined by
FACS® analysis.
Results
Generation of a6A Integrin–deficient Mice
The two cytoplasmic variants a6A and a6B result from al-
ternative splicing of the a6 pre-mRNA (Cooper et al.,
1991; Hogervorst et al., 1991). In the case of the variant A,
exon A is inserted in the a6 mRNA, and the presence of a
stop codon at the 39 end of exon A prevents translation to
continue further into exon B. In the case of a6B, an a6
RNA transcript is produced that lacks exon A sequences.
To define the function of the two a6 variants in the de-
velopment of the mouse and to determine whether a6B
could functionally replace a6A, we specifically deleted the
exon A. To this end, we have used a gene targeting ap-
proach combining classical methods of gene inactivation
by homologous recombination and the use of the Cre-loxP
system (Fig. 1 A). This technique has been successfully
used to generate knockout mice in which the exon coding
for a splice variant of the b1 integrin subunit was selec-
tively deleted (Baudoin et al., 1998). The Cre recombinase
of the bacteriophage P1 excises DNA residing between re-
Figure 1. Strategy for exon A targeting. (A) Re-
striction maps of the 39 end of the mouse a6 inte-
grin gene, the targeting vector, the homologous
recombinant allele, and the exon A–deleted mu-
tant are shown. The targeting vector was de-
signed to replace exon A by a neo-tk cassette
flanked by two loxP sites. After homologous re-
combination, ES cells were transiently trans-
fected with a plasmid encoding the Cre enzyme,
which resulted in the removal of the neo-tk cas-
sette, leaving a single loxP site behind. Homolo-
gously recombined clones were identified by
Southern blot analysis as those containing a new
7.5-kb BglII fragment on hybridization with a
cDNA probe corresponding to exon B. (B) In
wild-type cells expressing a6A, exon A is spliced
into the mature a6 mRNA together with exon B,
which contains the polyadenylation sequence. In
knockout cells, the exon encoding the transmem-
brane region (exon T) and exon B are connected
in the mature a6 mRNA, leading to the exclusive
expression of a6B.Gimond et al. In Vivo Role of the a6A Integrin Splice Variant 257
peats of 34 bp termed loxP sites, leaving one loxP site in
the gene locus (Sauer and Henderson, 1988). We made use
of this property to delete the selection marker cassette af-
ter inactivation of exon A. We predicted that the removal
of the 4.8-kb cassette would allow normal splicing between
the exon coding for the transmembrane domain of the in-
tegrin subunit and exon B (Fig. 1 B), and thus only a6B
was expected to be expressed in all tissues that normally
express a6A.
In the first step, a lFIX-II 129/Sv mouse genomic library
was screened with a cDNA probe corresponding to the
exon coding for the cytoplasmic domain of a6A. One of
the resulting clones, ma6Al1, was characterized further,
and its restriction map is shown in Fig. 1 A. The position of
exon A and exon B was determined by PCR using oligo-
nucleotides specific for these exons. The vector was de-
signed to replace exon A and the exon–intron boundaries
by a selection marker cassette containing the neor gene for
positive selection and the HSV-thymidine kinase gene for
negative selection.
The linearized targeting vector was transfected in E14
ES cells by electroporation, and cells were subjected to
positive selection (G418). Cell clones containing a recom-
bined a6 allele were identified by Southern blot analysis
after digestion of genomic DNA with BglII and hybridiza-
tion with a cDNA probe corresponding to exon B. Tar-
geted clones yielded a 7.5-kb band in addition to the 10-kb
band corresponding to the wild-type allele (Fig. 2 A). 30%
of the resistant clones were positive for homologous re-
combination.
Clones that had undergone homologous recombination
were transfected with a Cre-encoding plasmid and sub-
jected to negative selection (gancyclovir). As the size of
the loxP site remaining in the gene is smaller than that of
exon A, PCR was used to identify the resistant colonies in
which Cre-loxP–mediated recombination had occurred
(Fig. 2 B), and the results were confirmed by Southern
blot analysis (not shown). 90% of the resistant clones
scored positive for Cre-loxP–mediated recombination.
Two independent a6A1/2 clones were used to generate
chimeric males, which transmitted the mutated allele to
their progeny. Mice heterozygous for the mutation in the
a6 integrin gene were identified by PCR analysis on tail
DNA (Fig. 2 C).
Deletion of Exon A Causes Replacement of a6A by a6B 
in Tissues That Normally Express a6A
Intercrossing heterozygous animals produced offspring
homozygous for the deletion, which occurred in the ex-
pected mendelian frequency. Such animals developed ap-
parently normally and were fertile. These surprising re-
sults indicate that a6B can fully functionally replace a6A
in mouse development. We first verified that the deletion
of exon A caused a6A to be replaced by a6B in the em-
bryonic myocardium by using antibodies directed against
the cytoplasmic domain of a6A or a6B on tissue sections
of wild-type (a6A1/1) and a6A2/2 embryos collected at
12.5 dpc (Fig. 3). As previously described (Collo et al.,
1995; Thorsteinsdóttir et al., 1995), the a6A variant is ex-
pressed in the myocardium of the atria and the ventricles
of 12.5 dpc a6A1/1 embryos, and although a reaction was
seen throughout the ventricle wall, the protruding cells at
the inner face of the ventricular myocardium reacted more
intensely than the peripheral cells. No staining for a6B
could be detected in the myocardium. A weak staining of
the blood vessels feeding the heart was observed with anti-
a6B antibodies and probably corresponded to the expres-
sion of this variant in endothelial cells (Thorsteinsdóttir et
al., 1995). This was in agreement with finding a6B mRNA
by reverse transcription PCR in heart preparations (Thor-
steinsdóttir et al., 1995). In contrast, the somites, the kid-
neys, and the head of the embryo strongly reacted with the
anti-a6B antibody (not shown).
As predicted, no a6A was detected in the myocardium
of a6A2/2 embryos of 12.5 dpc. In contrast, a6B was
found to have replaced a6A and was now present in the
atria and ventricles in a gradient, the expression being
strongest at the inner face of the ventricular myocardium
and weakening towards the peripheral cells, similar to the
gradient of expression of a6A in control mice.
These data demonstrate that the specific removal of
exon A using homologous recombination and the Cre-
loxP system resulted in the replacement of a6A by a6B in
a tissue that normally expresses a6A.
a6B Takes Over the Function of a6A in
Heart Development
The viability of the a6A2/2 mice and the normal mor-
phology of atria and ventricles of 12.5-dpc a6A2/2 em-
bryos suggested that cardiogenesis was not affected by the
replacement of a6A by a6B. Careful histological analysis
Figure 2.( A ) Identification of homologous recombination in ES
cells by Southern blot analysis. Lanes 1 and 5, a BglII digest of ES
cell clones in which recombination did not occur; lane 3, a clone
in which random recombination had occurred; lanes 2 and 4, two
ES cell clones (6A4 and 9H4) in which homologous recombina-
tion had occurred. (B) Identification of Cre-loxP–mediated re-
combination in ES cells by PCR. The 289-bp band in lane 1 repre-
sents the wild-type allele, whereas the 246-bp band in lanes 2 and
3 represents the Cre-loxP–targeted allele. (C) PCR analysis of
the genotypes. Lane 1, the genotype of a wild-type mouse; lane 2,
a mouse heterozygous; lane 3, one homozygous for the mutation.The Journal of Cell Biology, Volume 143, 1998 258
of the heart was conducted on 10.5- and 12.5-dpc embryos
to investigate whether there were any subtle morphologi-
cal defects due to the mutation, but no aberrations in the
morphology of the heart and cardiomyocyte organization
were observed at these stages (not shown). We tested the
possibility that the normal development of the heart in the
a6A2/2 mice could be the result of compensatory mecha-
nisms involving other laminin-binding integrins such as
a3b1 and a7b1. These integrins were found to be absent in
the myocardium of both control and knockout 12.5-dpc
embryos (not shown), suggesting that a6B alone can take
over the function of a6A in the formation of the heart.
Replacement of a6A by a6B Does Not Impair
the Differentiation of the Epidermis, Hemidesmosome 
Formation, or Wound Closure
Although a6B is present in the epidermis of the embryo
(Thorsteinsdóttir et al., 1995), only a6A is expressed there
after birth and in the adult, in association with the b4 inte-
grin subunit. However, no obvious abnormalities were de-
tected in histological sections of the epidermis of a6A2/2
mice (not shown). The substitution of a6A by a6B in the
epidermis of the knockout mice was first confirmed with
antibodies directed against a6A or a6B (Fig. 4 A). In con-
trol animals, the staining for a6A was restricted to the
basal keratinocyte layer, and a weak staining of the blood
vessels in the dermis corresponding to that of a6B in en-
dothelial cells was observed. As expected, a6A was not ex-
pressed in the epidermis of the knockout mice and was re-
placed by a6B. The absence of a6A in skin was confirmed
by Northern blot analysis (not shown).
Ultrastructural analysis revealed that hemidesmosomes
were normal in number and morphology in the skin of
knockout animals (Fig. 4 B), indicating that a6B in associ-
ation with b4 supports hemidesmosome formation. Since
the a6b4 integrin is redistributed from the hemidesmo-
somes to a more even distribution over the membrane
during keratinocyte migration (Kurpakus et al., 1991), we
investigated whether the replacement of a6A by a6B
would lead to the disassembly of hemidesmosomes and, as
a consequence, would affect keratinocyte migration during
wound healing. Therefore, a wound closure experiment by
tail amputation was conducted on a6A1/1 and a6A2/2
mice. Keratinocyte migration was assessed at day 2 and 4
after amputation of the tail by hematoxylin/eosin staining.
No apparent irregularities were detected in the epidermis
of the reepithelializing skin, and wounds healed as quickly
in the a6A2/2 mice as in the control mice (Fig. 4 C).
Together, these results show that the differentiation of
the epidermis, hemidesmosome formation, and reepithe-
lialization after wound healing in mice expressing only the
variant a6B are normal.
Keratinocyte Adhesion and Motility Are Not Altered in 
a6A2/2 Mice
To further confirm the replacement of a6A by a6B in the
epidermis and to study the adhesion of the a6A2/2 kera-
tinocytes and their migration properties, we isolated kera-
tinocytes from newborn mice and cultured them in vitro.
At none of the passages was the morphology of a6A2/2
cells different from that of control keratinocytes (not
shown). The pattern of expression of laminin-binding inte-
grins on both cell types was analyzed by immunoprecipita-
tion from 125I-labeled cells (Fig. 5 A). The a6A variant but
not a6B was precipitated from a6A1/1 keratinocytes. On
the contrary, a6A was not expressed at the surface of
a6A2/2 keratinocytes. It had been replaced by a6B. As
expected, the expression of the a3A, b4, and b1 chains was
not altered by the deletion. The absence of a band corre-
sponding to the a6 polypeptide in the b1 immunoprecipi-
tates indicated that mouse keratinocytes, like those of hu-
mans, do not express a6b1.
Data obtained by Tennenbaum et al. (1995) revealed
that the introduction of the a6B variant in a papilloma cell
Figure 3. Deletion of exon A
leads to replacement of a6A
by  a6B in the embryonic
heart. Embryonic heart sec-
tions from control (1/1) and
knockout (2/2) mice were
prepared and subjected to
immunohistochemistry with
anti-a6A (1A10) or anti-a6B
(PB36) antibodies, followed
by incubation with an FITC-
conjugated secondary anti–
mouse antibody. Note that
the atria (A) and ventricles
(V) but not the endocardiac
cushion (EC) express a6.
Bar, 100 mm.Gimond et al. In Vivo Role of the a6A Integrin Splice Variant 259
Figure 4. Differentiation of
the epidermis, hemidesmo-
some formation, and wound
closure are not impaired in
a6A2/2 mice. (A) Skin sec-
tions from control (1/1) and
knockout mice (2/2) were
incubated with anti-a6A or
anti-a6B antibodies. Note the
presence of an apparently
normal pluristratified epithe-
lium in the knockout mice.
(B) Electronic microscopy
analysis revealed the pres-
ence of normal hemidesmo-
somes in the skin of a6A2/2
mice. (C) Wounds were made
by amputation of the tail, and
reepithelialization was ana-
lyzed using hematoxylin/
eosin–stained sections. After
2 d, the cells had migrated
half the distance between the
wound edge and the protrud-
ing bone (shown). After 5 d,
cells had completely covered
the wounds (not shown). Bar,
50 mm.The Journal of Cell Biology, Volume 143, 1998 260
line induced an increase of the adhesion of these cells to
laminin-1, which is a ligand for a6b4 (Lee et al., 1992;
Niessen et al., 1994). We have assessed the adhesion of ke-
ratinocytes to laminin-1, which interacts with a6b4, to
laminin-5, involving both a3b1 and a6b4, and to fibronec-
tin, mediated by a5b1 and av integrins. As shown in Fig. 5
B, the adhesion properties of a6A1/1 and a6A2/2 kera-
tinocytes on all three substrates are similar.
Finally, because in vivo wound healing involves both cell
migration and proliferation, we investigated the migratory
properties of a6A2/2 keratinocytes in vitro using Trans-
well filters coated with laminin-1, laminin-5, or fibronectin
on the lower side. We could not observe any significant
difference in the motility of the two cell types after 6 or 18 h
of migration (not shown). These results indicate that sub-
stitution of a6A by a6B does not modify keratinocyte ad-
hesion and motility.
Replacement of a6A by a6B Does Not Affect 
Lymphocyte Differentiation and Proliferation but 
Reduces the Motility of These Cells
In the thymus during development, the expression of a6A
and a6B is regulated in both the thymocytes and the en-
dothelial cells (Chang et al., 1995; Ruiz et al., 1995). In ad-
dition, it has been previously shown that the homing of T
cell precursors into the thymus is blocked by anti-a6 anti-
bodies (Ruiz et al., 1995). Therefore, it was expected that
T lymphocyte differentiation might be impaired in our
a6A2/2 mice. Furthermore, laminin has been shown to
promote the proliferation of thymocytes and T cells plated
on anti-CD3 antibody (Shimizu et al., 1990a; Chang et al.,
1995). Finally, lymphocytes encounter different laminin
isoforms as they recirculate and transmigrate through the
basement membranes underlying the endothelial cells in
secondary lymphoid organs and at sites of inflammation.
The receptor for laminin on T cells is a6b1 (Shimizu et al.,
1990b), and because the cytoplasmic domain of a6A might
give a specific signal to lymphocytes upon interaction with
laminin, we investigated the ability of a6B to sustain T cell
differentiation, proliferation, and migration.
a6A was only present in the T cells of lymph nodes from
control mice and not in those from knockout mice, while
a6B was expressed in a6A2/2 T cells as determined by
reverse transcription PCR (not shown). The levels of ex-
pression of the a6 subunit were the same on both cell
Figure 5. Analysis of integrin expression and adhesion properties of a6A1/1 and a6A2/2 keratinocytes. (A) Lysates of 125I-labeled
control and knockout keratinocytes were immunoprecipitated with antibodies against the following integrin subunits: a6 (lanes 1 and 7),
a6A (lanes 2 and 8), a6B (lanes 3 and 9), a3A (lanes 4 and 10), b4 (lanes 5 and 11), and b1 (lanes 6 and 12). a6A1/1 and a6A2/2 ke-
ratinocytes express the a6A and the a6B subunits, respectively, in association with the b4 subunit (200 kD). The band around 116 kD in
the a6 precipitates is a degradation product of b4. Both types of cells express a3 (150 kD) in association with b1 (120 kD). Samples were
analyzed on SDS 5% acrylamide under nonreducing conditions. (B) a6A1/1 (closed circles) and a6A2/2 (open circles) primary kera-
tinocytes adhered equally well to laminin-1, laminin-5, or fibronectin.Gimond et al. In Vivo Role of the a6A Integrin Splice Variant 261
types as determined by FACS® analysis using the GoH3
antibody (not shown). Differentiation of the T cell-lineage
was assessed by reactivity of total cell suspensions isolated
from the thymus of age- and sex-matched control and
knockout mice with anti-CD3 (Fig. 6 A). A normal per-
centage of strongly CD3-positive T cells was found in the
thymus of a6A2/2 mice. Moreover, CD4/CD8 ratios
were similar in knockout and control mice, indicating that
the development of various T cell subsets proceeds nor-
mally in the presence of a6B alone. As the presence of a6
integrin on B cells has been reported in one study (Ohguro
and Tsubota, 1996), we also studied B cell maturation us-
ing antibodies directed against B220/CD45R and IgM on
spleen cells. Fig. 6 B shows that their differentiation is not
affected in a6A2/2 mice.
To determine whether the substitution of a6A by a6B
affected the proliferative response triggered by laminin-1,
we conducted costimulation experiments by incubating
purified lymph node T cells on plate-bound laminin-1 and
anti-CD3 antibody for 48 h (not shown), 72 h (Fig. 7), or
96 h (not shown). While the incorporation of [3H]thymi-
dine was low in cells stimulated by anti-CD3 antibody
alone, costimulation by soluble anti-CD28 antibody (Gross
et al., 1992) showed that a6A1/1 and a6A2/2 T cells dis-
played the same ability to proliferate. More importantly,
incorporation of [3H]thymidine was found to be increased
by binding to laminin-1 to the same extent in T cells iso-
lated from knockout mice and control animals, indicating
that the proliferative response to laminin-1, although a6b1
mediated (Shimizu et al., 1990a), is not dependent on the
nature of the cytoplasmic domain of a6.
Finally, the ability of a6B to support migration of cells
of the immune system was studied. Although a6A has pre-
viously been reported to increase motility of cells of a
macrophage cell line on laminin-1 (Shaw and Mercurio,
1994), we could not investigate the effects of the absence
of a6A in cells of this type because laminin-1 failed to sup-
port attachment and migration of peritoneal macrophages
isolated from either our control or knockout mice (not
shown). Migratory properties of T lymphocytes were first
studied in vitro using Transwell filters coated with either
laminin-1 or fibronectin, and in the presence of the
chemoattractant SDF-1, in the lower compartment of the
chamber. Interestingly, we have found that the motility of
a6A2/2 T cells was reduced by 46% compared with that
of control cells on laminin-1–coated filters, whereas migra-
tion through fibronectin-coated filters was not affected
(Fig. 8 A). Similar results were obtained with another
chemoattractant, MCP-1 (not shown). Importantly, the
decrease in cell migration was not due to differences in the
activation state of T cells from both normal and knockout
mice, as verified by the expression of the activation
marker CD69 (not shown). Finally, a decrease in cell mo-
tility was observed in cells originating from two indepen-
dent ES cell clones. This indicates that optimal migration
Figure 6. T and B lymphocytes lacking a6A develop normally.
(A) Thymic cells from control and a6A2/2 mice were incubated
with either PE-conjugated anti-CD3e (top) or with a combination
of FITC-conjugated anti-CD4 and PE-conjugated anti-CD8 anti-
bodies, and analyzed by flow cytometry. (B) Splenic lymphocytes
from control and knockout mice were incubated with biotin-con-
jugated anti-B220/CD45R and FITC-conjugated anti-IgM anti-
bodies and analyzed by flow cytometry.
Figure 7. Costimulation of CD3-mediated T cell proliferation by
laminin-1. Wells of microtiter plates were first coated with anti-
CD3 antibodies and, when indicated, with 1 or 10 mg/ml laminin-1.
Costimulation of proliferation in the presence of soluble anti-
CD28 antibody was taken as a control. The experiment shown is
one representative experiment out of five.The Journal of Cell Biology, Volume 143, 1998 262
of T lymphocytes is dependent on the expression of the cy-
toplasmic domain of a6A.
After T cell purification, we consistently observed a
strong decrease (30–40%) in the absolute number of cells
isolated from the peripheral and mesenteric lymph nodes
of a6A2/2 mice (Fig. 8 B). To test the hypothesis that this
could be due to alterations in the migration of T cells to
the lymph nodes, we have conducted in vivo lymphocyte
homing experiments using PKH2 and PKH26 fluorescent
cell linkers. Lymph node cells from a6A1/1 and a6A2/2
cells were labeled with one of the fluorescent cell linkers,
mixed in equal number, and injected into the tail vein of
wild-type animals. The percentage of each cell type in the
cell mixture was checked by FACS® analysis and was close
to 50% (not shown). Fluorescent-labeled cells homing into
spleen, peripheral, and mesenteric lymph nodes was deter-
mined by FACS® analysis 2 or 20 h after the injection.
Two series of experiments were performed with the injec-
tion of either PKH2-labeled a6A1/1 and PKH26-labeled
a6A2/2 cells or PKH2-labeled a6A2/2 and PKH26-
labeled a6A1/1 cells. Results obtained with both combi-
nations were similar and are presented in Table I. The
frequency of a6A2/2 cells in spleen, peripheral, and me-
senteric lymph nodes was comparable to that of the
a6A1/1 lymphocytes 2 h after injection. A higher per-
centage of cells were found in the lymph nodes after 20 h
of homing, but no significant difference could be observed
between the two cell types.
Together, these data suggest that, although the expres-
sion of a6A is necessary for the optimal migration of T
cells on laminin-1 in vitro, it is dispensable for in vivo lym-
phocyte homing to the secondary lymphoid organs.
Discussion
Development Is Not Impaired in Mice Expressing Only 
the a6B Variant
Classical ES cell technology combined with the Cre-loxP
system of the bacteriophage P1 was used to create exon-
specific knockout mice that did not express the A variant
of the a6 integrin subunit. The deletion resulted in the re-
placement of a6A by a6B in all tissues that normally ex-
press a6A, such as the developing heart, in which a6A is
associated with the b1 subunit, and the adult epidermis, in
which a6Ab4 is expressed in the basal keratinocyte layer.
Previous studies have indicated that a6 is apparently not
essential for proper prenatal development (Georges-
Labouesse et al., 1996). However, the importance of a6A
Figure 8. The motility of a6A2/2 T lymphocytes is reduced on
laminin-1. (A) T lymphocytes from lymph nodes were allowed to
migrate through fibronectin- or laminin-1–coated Transwell fil-
ters for 2 h in the presence of 10 ng/ml SDF-1 in the lower com-
partment of the wells. Note that the migration of a6A2/2 T cells
is reduced on laminin-1 only and not on fibronectin. The experi-
ment shown is one representative experiment out of four. (B)
Lymph nodes from a6A2/2 mice contain fewer cells than their
normal counterparts. T cells from the peripheral and mesenteric
lymph nodes of five control and five a6A2/2 mice were purified
and counted. Mean values are 9.2 3 106 6 0.7 (a6A1/1) and
5.75 3 106 6 1.2 (a6A2/2).
Table I. Homing of Fluorescence-labeled a6A1/1 and
a6A2/2 Lymphocytes to Spleen, Peripheral Lymph Nodes, 
and Mesenteric Lymph Nodes
2 h 20 h
Cells Spleen
Peripheral
lymph nodes 
Mesenteric
lymph nodes
Peripheral and mesenteric
lymph nodes
a6A1/1 3.66 6 0.69 1.18 6 0.12 0.97 6 0.29 2.26
a6A2/2 3.85 6 0.76 1.21 6 0.45 0.74 6 0.17 2.48
Cells were isolated from the peripheral and mesenteric lymph nodes of a6A1/1 and
a6A2/2 mice and labeled with either PKH2 or PKH26 as described in Materials and
Methods. 3 3 107 a6A1/1 and a6A2/2 cells were injected into wild-type recipient
mice. After 2 or 20 h, cell suspensions were isolated from the spleen, peripheral lymph
nodes, and mesenteric lymph nodes of the recipient mice and subjected to FACS®
analysis to determine the percentage of a6A2/2 versus a6A1/1 cells in each sus-
pension. Values after 2 h homing are the means 6 SEM obtained from a total of six
recipient mice in two independent experiments. Mean for two mice are indicated after
20 h homing.Gimond et al. In Vivo Role of the a6A Integrin Splice Variant 263
for the function of the epidermis, mature gonads, Schwann
cells, and the immune system could not be addressed since
a62/2 pups die shortly after birth because of detachment
of the epidermis. Moreover, it was not possible to investi-
gate the consequences of the lack of a6A during cardio-
genesis on the function of the adult heart. We show here
that a6B can sustain normal mouse development until ma-
turity and that a6A2/2 animals are fertile. We did not de-
tect any abnormalities in either the morphology or the his-
tology of various organs and tissues, and we argue that the
presence of exon A in a6 mRNA is not essential for the
proper control of cell migration and proliferation during
development. These findings were surprising in the light of
the recently published work by Domanico et al. (1997),
who have shown that the ectopic expression of a6A in un-
differentiated ES cells conferred a highly migratory phe-
notype to these cells as compared with their normal coun-
terparts, which express only a6B. Importantly, these
stimulatory effects on cell migration were found to be in-
dependent from adhesion to laminin-1, suggesting that the
cytoplasmic domain of a6A was sufficient for promoting
motility. However, our own results unequivocally show
that the cytoplasmic tail of a6B can support cell migration
during development.
Heart Development and Function Are Normal in 
a6A2/2 Mice
Most surprising was the absence of an apparently abnor-
mal phenotype during heart ontogeny in a6A2/2 mice.
While a6B is expressed throughout development, the ex-
pression of a6A begins at 8.5 dpc and is initially restricted
to the developing myocardium (Collo et al., 1995; Thor-
steinsdóttir et al., 1995). The onset of a6A expression im-
mediately precedes the initiation of the looping process,
which converts anterior–posterior patterning of the heart
tube into left–right asymmetry (Fishman and Olson, 1997),
strongly suggesting a critical role of this integrin subunit in
cardiogenesis. Although a62/2 mice did not present any
abnormalities of the heart (Georges-Labouesse et al.,
1996), we assumed that the replacement of a6A by a6B,
while not preventing adhesion to laminin substrata, could
result in the transmission of inappropriate molecular sig-
nals into the cardiomyocytes and thus could have more
profound effects on heart formation than the complete ab-
sence of a6. Surprisingly, histological analysis and immuno-
fluorescence data revealed no overt abnormal phenotype
of the heart, and the pattern of expression of a6B was sim-
ilar to that of a6A in control mice, the inner cells of the
myocardium being more intensely stained than the periph-
eral cells. Because an abnormal phenotype is more likely
to be detected in a simplified, in vitro differentiation
model (Bagutti et al., 1996), double knockout ES cells
were generated and aggregated into embryoid bodies. We
found that a6A2/2 ES cells displayed the same ability to
differentiate into cardiac contracting cells as their wild-
type counterparts (Gimond, C., unpublished results), fur-
ther supporting the finding that the substitution of a6A by
a6B is compatible with normal cardiogenesis. Finally, this
substitution does not seem to impair the function of the
adult heart either, since the level of the atrial natriuretic
peptide, a marker of heart dysfunction (Edwards et al.,
1988), was normal in the ventricles of our a6A knockout
mice (our unpublished results).
Although the simplest explanation for the lack of an
overt abnormal phenotype in the heart is that a6B, in spite
of its different cytoplasmic domain, can substitute for a6A
during cardiomyocyte differentiation and reorganization,
more complex compensatory mechanisms, involving other
laminin-binding receptors, might have occurred during de-
velopment. However, if compensation occurred, our re-
sults show that this is not due to the induction of the ex-
pression of two other laminin-binding integrins, a3Ab1
and  a7b1.
Keratinocytes Expressing a6B Assemble 
Hemidesmosomes and Display Normal Adhesive and 
Migratory Properties
In contrast to the embryonic heart, in which a6A is com-
plexed with the b1 subunit, in developing epidermis both
a6A and a6B are expressed in association with the b4 sub-
unit (Thorsteinsdóttir et al., 1995). Only a6A remains af-
ter birth, and although the reasons for the loss of expres-
sion of a6B in this tissue is not clear, the expression
patterns of the two variants might correspond to key
stages in skin development or to specific physiological
conditions. However, the epidermis apparently differenti-
ated normally in a6A2/2 mice, and more importantly, it
contains hemidesmosomes in normal number and of nor-
mal morphology. This is interesting because phosphor-
ylation of a6A was thought to be required for the nucle-
ation of hemidesmosome assembly (Baker et al., 1997).
Thus, although a6B was never found to become phosphor-
ylated, it is capable, in association with b4, of supporting
hemidesmosome formation. This suggests that, for this
function of a6, only binding to laminin, which does not de-
pend on the cytoplasmic domain of the subunit, is re-
quired. Alternatively, the cytoplasmic domain of a6B may
render conformation of a6b4 permissive for hemidesmo-
some formation. Nevertheless, the substitution of a6A by
a6B might have subtle effects on the regulation of the as-
sembly or the disruption of hemidesmosomes, in which b4
is involved (Dowling et al., 1996; van der Neut et al., 1996),
and although the migration of keratinocyte per se was
found to be independent of a6b4 (Kurpakus et al., 1991),
the cytoplasmic domain of this integrin might play a role in
hemidesmosome disassembly and the onset of cell move-
ment. However, given our results both in vivo and in vitro,
it appears that the expression of only a6B does not per-
turb keratinocyte migration and wound closure.
Previous work by Tennenbaum et al. (1995) has shown
that overexpression of a6B in a papilloma cell line re-
sulted in increased binding to laminin-1, whereas overex-
pression of a6A had no effect on adhesion. In contrast to
those results, we show that when using an in vivo approach
in which the expression level of a6 is not modified, adhe-
sion properties of keratinocytes expressing either the one
or the other splice variant are not different.
Lymphocyte Motility Is Reduced in a6A2/2 Mice
During maturation of the immune system, recirculation,
and inflammation, lymphocytes encounter different lami-
nin isoforms as they cross the basement membrane under-The Journal of Cell Biology, Volume 143, 1998 264
lining various blood vessels (Springer, 1994). In addition,
laminin-1, -3, and -5, together with other extracellular ma-
trix proteins, are present in the stroma of various lym-
phoid organs such as the thymus and lymph nodes and in
the bone marrow (Chang et al., 1993; Jaspars et al., 1996),
in which lymphocytes proliferate and differentiate. The
production of laminins by these tissues is mirrored by the
stronger expression of a6 integrins on immature than on
mature T cells (Ruiz et al., 1995), suggesting a critical role
of laminin–integrin interactions in the differentiation pro-
cess. Moreover, a6 expressed by thymic endothelial cells
was shown to participate in the homing of T cell progeni-
tors to this organ (Ruiz et al., 1995). A differential role for
the cytoplasmic domains of the a5 and a6 subunits in me-
diating signals for proliferation and differentiation has re-
cently been described in myoblasts (Sastry et al., 1996),
and because of their entirely different cytoplasmic do-
main, we expected the ability of a6A and a6B to regulate
these cellular responses to be different. It was therefore
surprising to find that T and B cells differentiated nor-
mally in a6A2/2 mice and that the a6-dependent costim-
ulatory effect of laminin-1 on T cell proliferation (Shimizu
et al., 1990a; Chang et al., 1995) can be transmitted as effi-
ciently by a6B as by a6A. This finding might be explained
by the critical function of the cytoplasmic tail of the b sub-
unit in cell growth (Merredith and Schwartz, 1997). Alter-
natively, the adhesion-dependent activation of integrin-
associated protein could be involved in the induction of
proliferative signals in T cells regardless of which integrin
is ligated (Reinhold et al., 1997). Finally, adhesion of lym-
phocytes to extracellular matrix proteins in the bone mar-
row or in the thymus might be sufficient to allow their sus-
tained interaction with stromal cells and stimulation by
cytokines, which are the conditions for proper selection
and differentiation (Anderson et al., 1996). In that case,
substitution of a6A by a6B is not expected to affect matu-
ration, since the ligand-binding activities of the two splice
variants are identical.
Interestingly, the motility of a6A2/2 T cells through
laminin-1-coated filters was markedly decreased. A pro-
moting effect of a6A on cell migration has already been
reported (Shaw and Mercurio, 1994; Domanico et al.,
1997), but in previous work, the effects of ectopic and
overexpression of either one or the variants in two differ-
ent cell lines was analyzed. In the present paper, we show,
for the first time, that the endogenous expression of a6A
more efficiently supports the migration of primary T lym-
phocytes in vitro. When overexpressed in ES cells, a6A
was reported to enhance migration not only on laminin-1
but also on other extracellular matrix proteins that do not
use a6b1 as a receptor (Domanico et al., 1997). Yet, we
show here that the effects of the absence of a6A on T cell
migration only occur on laminin-1. We have also observed
that the number of T cells isolated from the lymph nodes
was consistently lower in the a6A2/2 than in wild-type
mice. Since lymphocytes must cross basement membranes
containing laminins when recirculating through the organ-
ism, one hypothesis for this difference is that impaired mi-
gration of a6A2/2 cells could result in a less efficient
homing to the peripheral and mesenteric lymph nodes,
causing the number of cells in these organs to be lower. In
this regard, it is interesting to note that antilaminin anti-
bodies were found to inhibit lymphocyte trafficking and
homing to the peripheral lymph nodes (Kupiec-Weglinski
and De Sousa, 1991). However, we could not demonstrate
any defects in lymphocyte homing in our a6A2/2 mice,
which indicates that the reduced cell number in lymph
nodes has other causes, e.g., defects in cell proliferation.
Although we have shown that the substitution of a6A by
a6B does not affect T cell proliferation in vitro in condi-
tions where both CD3 and a6b1 are ligated, the lack of
a6A in lymphocytes or in lymph node stromal cells might
lead to a decrease in lymphocyte proliferation in vivo.
The altered cell motility on laminin-1 that we observed
in vitro does not seem to have consequences for lympho-
cyte homing. This might be due to the ability of lympho-
cytes to use several other integrins from their repertoire to
migrate on the various extracellular matrix proteins
present in basement membranes, and the lack of a6A is
likely to be compensated by other types of integrin–matrix
interactions. Such compensatory mechanisms cannot be
used by lymphocytes migrating on a laminin-1 matrix, and
therefore, defects resulting of the absence of a6A are
more likely to be detected in vitro. Redundancy and com-
pensatory mechanisms could also explain the absence of
effects of the lack of a6A on the development of the
mouse. Nevertheless, we cannot rule out that the promot-
ing role of a6A on cell motility might be important for the
fast recruitment of lymphocytes to sites of inflammation or
in other pathological conditions.
The molecular basis for the promoting effect of a6A on
cell migration has not yet been elucidated, but it might in-
volve the different ability of the two splice variants to trig-
ger the phosphorylation of certain cytoskeletal proteins
(such as paxillin; Shaw et al., 1995) that are involved in cell
migration (Aznavoorian et al., 1996; Tourkin et al., 1996).
In agreement with this notion is the induction of filopodia
in cells of both ES and macrophage cell lines by a6A
(Shaw and Mercurio, 1994; Domanico et al., 1997), which
reflects cytoskeleton rearrangements. Since the only struc-
tural differences between a6A and a6B reside in their cy-
toplasmic domains, it is clear that these unique sequences
are responsible for the transmission of distinct signals into
the cell. This is not restricted to the a6 subunit since Chan
et al. (1992), using chimeric integrin molecules, have previ-
ously shown that the unique intracellular domains of the
a2 and a4 integrin subunits triggered either collagen gel
contraction or cell migration, respectively. Whether the
cytoplasmic domain of the a chain itself is able to trans-
duce signals has not yet been elucidated. Alternatively, it
could regulate interactions of the cytoplasmic tail of b1
with intracellular proteins involved in transduction. Regu-
lation of the phosphorylation state of a6A, for example by
chemoattractants, might also play a role in cell motility.
Such a posttranslational regulation has never been re-
ported for a6B and may account partly for their distinct
functional properties. Finally, internalization of a6b1,
which is an important aspect of cell migration, could be
regulated by the cytoplasmic domains of a6A and a6B in a
different manner, although previous reports argue against
this suggestion (Gaietta et al., 1994).
In conclusion, the specific removal of exon A from the
a6 gene allowed us to study in detail the role of endoge-
nously expressed a6A in vivo and to determine whetherGimond et al. In Vivo Role of the a6A Integrin Splice Variant 265
a6B could functionally replace it. Our results revealed
that, in contrast to previous assumptions and despite its re-
markable up-regulation at the stage of the heart-looping
process, a6A is not essential for proper cardiogenesis and
cell migration during development. However, we have
demonstrated that the two splice variants a6A and a6B
are not equivalent in supporting lymphocyte migration on
laminin-1, and thus, although its absence does not impair
lymphocyte homing into the lymph nodes, a6A might con-
tribute to some aspects of host defense. The a6A2/2 mice
will provide a useful tool for future studies aiming at fully
understanding the molecular mechanisms activated by the
two cytoplasmic variants of a6.
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